Vertos Medical

Executive Summary

Vertos Medical, now operating as Stryker's Interventional Spine division, specializes in minimally invasive treatments for chronic back pain and spinal conditions. Its flagship mild® procedure, which treats lumbar spinal stenosis by removing excess ligament tissue, has established a strong foothold in the market. The portfolio also includes vertebral augmentation systems, bone tumor ablation, and the OptaBlate® basivertebral nerve ablation system. As part of Stryker, Vertos benefits from extensive commercial infrastructure and R&D resources, positioning it for accelerated adoption and pipeline expansion.

Upcoming Catalysts (preview)

• Q3 2026Expansion of mild® procedure indications into new patient populations or geographies80% success
• Q4 2026Publication of long-term clinical outcomes for OptaBlate® basivertebral nerve ablation70% success
• Q2 2027FDA clearance or 510(k) for next-generation device platform60% success